Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Commitment (own venture)

Rules 1.1.0 · as of 14 Sep 2026

Quote

Commitment (own venture)

“atai’s management believes these data support the concept of at-home use of PCN-101 in future studies.”
· Christian Angermayer Gives Insight on Future of Atai’s Ketamine Program · tweet

Microdose article reproducing Angermayer's X post on atai's Phase 1 subcutaneous PCN-101 (R-ketamine) bridging study after the January 2023 Phase 2 miss; he relays management's expectation that PCN-101 can be developed for at-home use.

The forecaster's own organization can make the outcome happen by its own decision: clinic openings, product launches, hires, trial starts, filings by their own company. Listed in the commitments table, never scored.